United Therapeutics (Nasdaq: UTHR) is a biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
Recent Mentions on Fool.com
- United Therapeutics' Stock Picked Up Steam in October: Time to Buy?
- United Therapeutics Corporation's Stock Slumped in August: Is It Now a Bargain?
- Maverick Capital: Here's What This Hedge Fund Company Has Been Buying
- Why United Therapeutics Corporation Stock Skyrocketed
- Can Pig Lungs Keep Growth Flying for United Therapeutics Shareholders?